Synthesis and biological activity of new schiff bases containing 4(3H)-quinazolinone ring system

International Journal of ChemTech Research

Volumn 2, Issue 2, 2010, Pages

  Revanasiddappa, Hosakere D ^a   Prasad, K Shiva ^a   Kumar, L Shiva ^a   Jayalakshmi, B ^b  

^a UNIVERSITY OF MYSORE   (India)

^b MSCW   (India)

Author keywords

3 amino 2 methyl 4(3H)quinazolinone; Anthelmentic; Antimicrobial; Antioxidant

Indexed keywords

2 METHYL 3 (4 NITROBENZYLIDENEAMINO)QUINAZOLIN 4(3H) ONE; 2 METHYL 3 (PYRIDINE 2YL METHYLENEAMINE)QUINAZOLIN 4(3H) ONE; 3 (2 HYDROXY BENZYLIDENEAMINO) 2 METHYLQUINAZOLIN 4(3H) ONE; 3 (2,4 DICHLOROBENZYLIDENEAMINO) 2 METHYLQUINAZOLIN 4(3H) ONE; 3 (4 HYDROXY 3 METHOXYBENZYLIDENEAMINO) 2 METHYLQUINAZOLIN 4(3H) ONE; 4(3H) QUINAZOLINONE DERIVATIVE; ANTHELMINTIC AGENT; ANTIINFECTIVE AGENT; ANTIOXIDANT; SCHIFF BASE; UNCLASSIFIED DRUG;

ANTHELMINTIC ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EARTHWORM; IN VITRO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NONHUMAN; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 77954734478     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Katritzky A. R., Rees C. W., Scriven E. F. V., Comprehensive heterocyclic chemistry II; Pergamon, Oxford, 1996.
2. Joule J. A., Mills K., Heterocyclic chemistry, Blackwell Science, Oxford, 2000.
3. Nicolaon K. C., Vourloinis D., Winssinger N., Baran P. S., The Art and Science of total synthesis at the Dawn of 21st centuary. Angew. Chem. Int. Ed. 2000, 39, 44-122.
4. Arya P, Chou D. T. H., Beak M. G., Diversity-Based Organic Synthesis in the Era of Genomics and Proteomics, Angew. Chem. Int. Ed. 2001, 40, 339-347.
5. Nagarajan Vembu, Elinor C. Spencer, Jean Lee, John G.Kelly, Kevin B. Nolanc and Marc Devocellec, 5-Chloro-3-hydroxy-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-one: supramolecular aggregation through a twodimensional network of N-H---- O and O-H---- O interactions, Acta Crystallographica Section E, 2006, 62, 5003-5005.
6. Yoshihisa Yamada, Toyonari Oine, Ichizo Inoue., 4-Oxo-1,2,3,4-tetrahydroqinazolines. V. Ring Expansion Reaction of 1-Methyl-3-phenyl-4-oxo-3,4-dihydroquinazolinium Bromide with Diazoalkanes, Bulletin of the chemical society of Japan, 1974, 47(2), 339-340.
7. Daidon G., Raffa D., Plescia S., and Mantione L., A.Synthesis and pharmacological study of ethyl 1-methyl-5-(substituted 3,4-dihydro-4-oxoquinazolin-3-yl)-1H-pyrazole-4-acetates.Eur J Med Chem.2001;36:737-742.
8. Sheldon R. A., Kochi J. K., Metal catalyzed oxidation of organic compounds, Academic Press, New York, 1981.
9. Liu D, Kwasniewska K. An improved agar plate method for rapid assessment of chemical inhibition or bidentate N-donor ligands-I, 1-benzylimidazole derivatives. Polyhedron. 1996; 15(8):1263-1276.
10. Ortiz de Montellano P. R., Cytochrome(P-450), structure, mechanism and biochemistry. plenum press, New York and London, 1986.
11. Ullrich V., Roots I., Hilderbrandt A., Estabrook R. W., Cooney A. H., Micrososomes and Drug oxidations, pergamon press, New York, 1975, 795.
12. Halliwll B., Gutteridge J. M. C., Free radicals in biology and medicine, 2nd edition, Clarendon press, Oxford, 1988, 543.
13. Sadana A K, Miraza Y, Aneja K R, Prakash O. Hypervalent iodine mediated synthesis of 1-aryl/ hetryl-1,2,4-triazole [4,3-a] pyridines and 1-aryl/ hetryl 5-methyl-1,2,4-triazole [4,3-a] quinolines as antibacterial agents, Eur. J. Med. Chem. 2003; 38: 533-536.
14. th ed. 1997.
15. Thorn G. W., Adams R. D., Braunwald E., Isselbacher K. J., Petersdrof R. G., Harrison's Principles of Internal Medicine., In: Mcgraw Hill Co, New York, 1977, 1088-1089.
16. Vigar Z., Atlas of Medical Parasitology, In: Second edition. P G Publishing House, Singapore, 1984, 216-217.
17. Shimada K. K., Fujikawa K., Yahara, T. Nakamure, Antioxidative properties of xanthin on autoxidation of soybean oil in cyclodextrin emulsion, J. Agric. Food. Chem, 1992, 40, 945-948.